SANA SANA BIOTECHNOLOGY
Health Care · Russell 2000
Next earnings: not announced yet
What 11 analyst firms say about SANA BIOTECHNOLOGY: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
10 rated views · 11 analyst/firm records · 11 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 5 reports on SANA from 5 analyst firms in the last 90 days (11 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it and 2 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: BofA Securities lowered its target from $7.00 (set 6 Jan 2026) to $6.00 on 14 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Bank of America Securities | Alex Stranahan | Buy | 14 Aug 2026 | 6.00 USD |
| Citigroup | Samantha Semenkow | Buy | 1 Jun 2026 | 12.00 USD |
| Citizens JMP | Reni Benjamin | Buy | 5 Mar 2026 | 8.00 USD |
| H.C. Wainwright | Emily Bodnar | Buy | 11 Aug 2026 | 7.00 USD |
| Jefferies | Roger Song | Buy | 1 Jul 2026 | 7.00 USD |
| Morgan Stanley | Maxwell Skor | Buy | 13 Mar 2026 | 12.00 USD |
| Rodman & Renshaw | Michael G King | Buy | 11 May 2026 | 16.00 USD |
| TD Cowen | Philip M Nadeau | Buy | 24 Aug 2026 | — |
| Wedbush | Martin Fan | Buy | 10 Aug 2026 | 7.00 USD |
| Weiss Ratings | Unnamed analyst | — | 21 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 3 Mar 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:16 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.